The University of Texas Medical Branch, Galveston

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The University of Texas Medical Branch, Galveston sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).

203 total trials 29 currently recruiting 117 completed early-phase tilt top decile by trial count

The University of Texas Medical Branch, Galveston: 203 sponsored US clinical trials, 29 recruiting.

The University of Texas Medical Branch, Galveston sponsors 203 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 117 completed. 19 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 4 trials.

Top-decile sponsor footprint

The University of Texas Medical Branch, Galveston ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 25/100

117 of 157 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

203 total, page 2 of 5

COMPLETED

Prospective Analysis to Detect Myometrial Cells in Peritoneal Washing in Patients Undergoing Minimally Invasive Hysterectomy Using Containment Bag at University of Texas Medical Branch

NCT05955651

COMPLETED Phase 4

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

NCT05782816

COMPLETED

Health Risks and Barriers to Management Across the PCOS Lifespan

NCT05769426

COMPLETED

Intravitreal Injection Site and Perceived Pain

NCT05640895

TERMINATED NA

Post-Brain Injury Walking and Balance Recovery Program

NCT05934773

COMPLETED

Do Bluetooth Noise Cancelling Headphones Improve the Quality of Care in Hearing Impaired Patients?

NCT05420038

COMPLETED NA

Tension Versus Tension- Free Foley Balloon for Cervical Ripening

NCT05404776

COMPLETED NA

Patient Priorities Care for Hispanics With Dementia

NCT05303194

TERMINATED NA

Above-Knee-High Application of Lower Limb Compression and Its Impact on Clinical Outcome in Patients Hospitalized With Heart Failure Exacerbation.

NCT05467735

COMPLETED NA

A Comprehensive Community Approach for Diabetes Prevention and Care for a Vulnerable Population in Galveston

NCT05097534

TERMINATED NA

Subcuticular Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery

NCT05112640

COMPLETED Phase 4

Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia

NCT05047211

COMPLETED

Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women

NCT05012202

COMPLETED NA

Tolerance of Centrifuge-induced Acceleration in Subjects With Diabetes Mellitus and Cardiac Arrhythmia

NCT05404789

COMPLETED

Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury

NCT05057377

COMPLETED NA

Gait Training in Post-Stroke Hemiparesis Hemiparesis

NCT04877249

COMPLETED

Genome-Wide Assocation Study in Patients With Brain Injury Associated Fatigue and Altered Cognition (BIAFAC)

NCT04548180

COMPLETED

Endocrine, Metabolic and Microbiome Influence on the Post-acute Sequelae SARS-CoV-2 (PASC)

NCT04860869

COMPLETED

Microbial Determinants of Dementia Risk in Type 2 Diabetics of Mexican Descent

NCT04602650

TERMINATED Phase 4

Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

NCT04594070

COMPLETED NA

Early Amniotomy Following Transcervical Foley Balloon in the Induction of Labor

NCT04573517

COMPLETED NA

The Effects of Video Game Warm-up on EyeSi Surgical Simulator Performance

NCT04334486

COMPLETED NA

Tactile Low Vision Labeling of Ophthalmic Drops

NCT04483882

COMPLETED NA

Pink Warrior 2: Teleconference-based Gaming Support

NCT04259905

TERMINATED NA

Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial

NCT04277962

COMPLETED NA

Telephone Counseling and Numberless Scales to Overcome Barriers to Adolescent Weight Loss

NCT04241939

TERMINATED NA

A Study of a Low-Carbohydrate Diet to Improve Maternal Health After Childbirth

NCT04045353

COMPLETED

Assessing Effects of Lateral Tilt on Cardiac Output Using a Non-invasive Technique

NCT04112719

TERMINATED Phase 1

Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity

NCT03954990

TERMINATED Phase 2

Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

NCT03913702

COMPLETED Phase 1

Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation

NCT03904615

COMPLETED NA

Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants

NCT03694613

COMPLETED NA

Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits

NCT03715036

COMPLETED Phase 4

Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery

NCT03887299

TERMINATED NA

Out of Plane Approach for Interscalene

NCT03785392

COMPLETED NA

A Meal-based Comparison of Protein Quality, Complementary Proteins and Muscle Anabolism

NCT03816579

COMPLETED NA

Easy Stretch Toolkit: A Pilot Study

NCT03423277

COMPLETED NA

Environment Analysis Inside an Investigational Prescription Bottle

NCT03752411

COMPLETED NA

Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®

NCT03665688

COMPLETED Phase 1

Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing

NCT03649932

COMPLETED NA

Narrative Visualization for Breast Cancer Survivors' Physical Activity

NCT03612596

COMPLETED Phase 3

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

NCT03554265

COMPLETED NA

Does Aromatherapy Decrease Postoperative Nausea and Vomiting?

NCT03577496

COMPLETED NA

Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial

NCT03510260

COMPLETED NA

Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population

NCT03404375

COMPLETED NA

Foley Bulb Insertion Method: Blind vs. Direct

NCT03450408

COMPLETED NA

Feasibility of a Physical Therapy Intervention on Older Adults With Hyperkyphosis or Forward Head Posture

NCT04114331

TERMINATED NA

3D Ultrasound-guided Labor Epidural Analgesia in the Morbid Obese Parturient

NCT03405311

TERMINATED Phase 4

Antibacterial-coated Sutures at Time of Cesarean

NCT03386240

COMPLETED NA

Interventions for Adolescent Obesity

NCT03004378

← Previous Page 2 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 24
Phase 2 27
Phase 3 4
Phase 4 15

What is open in the The University of Texas Medical Branch, Galveston pipeline

29 recruiting of 203 indexed (14% open); 117 completed (58%).

Phase mix: 19 late (III/IV) vs 51 early (I/II) (early-phase heavy).

Top condition: Stroke (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The University of Texas Medical Branch, Galveston: open-pipeline peers nationwide

Peers matched on 203 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15%20% Total trials Recruiting share The University of Texas Medical Branch, GalvestonNational Center for Complementary and Integrative Health (NCCIH)MedImmuneGenzyme, a Sanofi CompanyOHSU Knight Cancer InstituteAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 203 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this The University of Texas Medical Branch, Galveston page

203 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Medical Branch, Galveston or any single study.

  • 29 of The University of Texas Medical Branch, Galveston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition The University of Texas Medical Branch, Galveston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The University of Texas Medical Branch, Galveston pipeline card: 203 registered trials from official public datasets.Report a data error.